Search results
Results from the WOW.Com Content Network
Amyloid-related imaging abnormalities (ARIA) are abnormal differences seen in magnetic resonance imaging of the brain in patients with Alzheimer's disease. ARIA is associated with anti-amyloid drugs , particularly human monoclonal antibodies such as aducanumab . [ 1 ]
Amyloid beta immunostaining showing amyloid plaques (brown). Amyloid plaques (also known as neuritic plaques, amyloid beta plaques or senile plaques) are extracellular deposits of amyloid beta (Aβ) protein that present mainly in the grey matter of the brain.
Pittsburgh compound B (PiB) is a radioactive analog of thioflavin T, which can be used in positron emission tomography scans to image beta-amyloid plaques in neuronal tissue. Due to this property, Pittsburgh compound B may be used in investigational studies of Alzheimer's disease .
Sabalza said experts believe it relates to the removal of amyloid plaques from the brain Amyloid-Related Imaging Abnormalities – Hemorrhage (ARIA-H) occurs when small bleeding events in the ...
After a rejection last year, the Food and Drug Administration approved Amyvid, a dye for detecting beta-amyloid plaques in Alzheimer's. Eli Lilly's (NYS: LLY) 2010 purchase of Avid ...
New research is contradicting previously held views that only neurons secret beta-amyloid that forms toxic plaques, a marker of Alzheimer's disease in the brain. The study points to another ...
The development of florbetapir built on research done by William Klunk and Chester Mathis who had developed a substance they called Pittsburgh compound B as a means of detecting amyloid plaque, after analyzing 400 prospective compounds and developing 300 variations of the substance that they had discovered might work.
Primary age-related tauopathy (PART) is a neuropathological designation introduced in 2014 to describe the neurofibrillary tangles (NFT) that are commonly observed in the brains of normally aged and cognitively impaired individuals that can occur independently of the amyloid plaques of Alzheimer's disease (AD).